目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 GASTROINTESTINAL STENT MARKET
1.3.2 YEARS CONSIDERED FOR STUDY
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH APPROACH
FIGURE 2 GASTROINTESTINAL STENT MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS (GASTROINTESTINAL STENT MARKET)
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: BOSTON SCIENTIFIC CORPORATION
FIGURE 9 SUPPLY SIDE MARKET SIZE ESTIMATION: GASTROINTESTINAL STENT MARKET (2020)
FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR GASTROINTESTINAL STENT MARKET (2021-2026)
FIGURE 12 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
2.7 ASSESSMENT OF IMPACT OF COVID-19 ON GASTROINTESTINAL STENT MARKET

3 EXECUTIVE SUMMARY (Page No. - 49)
FIGURE 14 GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 15 GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2021 VS. 2026 (USD MILLION)
FIGURE 16 GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 17 GASTROINTESTINAL STENT MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 18 GEOGRAPHIC SNAPSHOT OF GASTROINTESTINAL STENT MARKET

4 PREMIUM INSIGHTS (Page No. - 53)
4.1 GASTROINTESTINAL STENT MARKET OVERVIEW
FIGURE 19 RISE IN INCIDENCE OF GASTROINTESTINAL CANCERS, IBD, AND OTHER DIGESTIVE DISEASES DRIVE GASTROINTESTINAL STENT MARKET GROWTH
4.2 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT AND COUNTRY
FIGURE 20 BILIARY STENT HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2020
4.3 GASTROINTESTINAL STENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 GASTROINTESTINAL STENT MARKET: REGIONAL MIX
FIGURE 22 NORTH AMERICA TO BE LARGEST MARKET FOR GASTROINTESTINAL STENT THROUGHOUT FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 56)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 GASTROINTESTINAL STENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rise in the incidence of gastrointestinal cancers, IBD, and other digestive diseases
TABLE 2 GLOBAL INCIDENCE OF COLORECTAL CANCER, 2020
TABLE 3 GLOBAL GASTROINTESTINAL CANCER INCIDENCE, 2020
5.2.1.2 Increasing healthcare expenditure on gastrointestinal procedures
FIGURE 24 EUROPE: COSTS OF GASTROINTESTINAL CANCERS (USD BILLION), 2018
5.2.1.3 Ongoing technological advancements in business space
5.2.1.4 Increasing preference for minimally invasive surgeries
5.2.2 RESTRAINTS
5.2.2.1 Major complications associated with GI stent implementation
TABLE 4 FREQUENCY OF MOST COMMON STENT-RELATED COMPLICATIONS IN VARIOUS ANATOMIC SITES
5.2.2.2 High cost of the procedure and limited reimbursement in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 Development of biodegradable and drug eluting stents
5.2.3.2 Growing healthcare sector in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory environment

6 INDUSTRY INSIGHT S (Page No. - 63)
6.1 TECHNOLOGY ANALYSIS
6.1.1 RECENT ADVANCES IN GASTROINTESTINAL STENTING TO OFFER IMPROVED STENT PATENCY AND REDUCED STENT-INDUCED COMPLICATIONS, RESULTING IN IMPROVED QUALITY OF LIFE
6.2 PRICING ANALYSIS
TABLE 5 PRICES FOR GI STENTS (USD)
6.3 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE
6.4 ECOSYSTEM MAPPING
FIGURE 26 GASTROINTESTINAL STENT MARKET: ECOSYSTEM ANALYSIS
6.5 SUPPLY CHAIN ANALYSIS
FIGURE 27 GASTROINTESTINAL STENT MARKET: STAKEHOLDERS IN SUPPLY CHAIN
6.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 GASTROINTESTINAL STENT MARKET: PORTER’S FIVE FORCES ANALYSIS
6.6.1 THREAT OF NEW ENTRANTS
6.6.1.1 High capital requirement
6.6.1.2 High preference for products from well-established brands
6.6.2 THREAT OF SUBSTITUTES
6.6.2.1 Substitute therapies for gastrointestinal stents
6.6.3 BARGAINING POWER OF SUPPLIERS
6.6.3.1 Presence of few raw material suppliers
6.6.3.2 Supplier switching cost
6.6.4 BARGAINING POWER OF BUYERS
6.6.4.1 Few companies offer premium products at global level
6.6.5 INTENSITY OF COMPETITIVE RIVALRY
6.6.5.1 Increasing demand for high-quality and innovative products
6.6.5.2 Lucrative growth potential in emerging markets
6.7 REGULATORY ANALYSIS
TABLE 7 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE GASTROINTESTINAL STENT MARKET
6.7.1 NORTH AMERICA
6.7.1.1 US
TABLE 8 US FDA: CLASSIFICATION OF MEDICAL DEVICES
6.7.1.2 Canada
6.7.2 EUROPE
6.7.3 ASIA PACIFIC
6.7.3.1 India
6.7.3.2 China
TABLE 9 NMPA MEDICAL DEVICE CLASSIFICATION
6.7.3.3 Japan
TABLE 10 PMDA: CLASSIFICATION OF MEDICAL DEVICES
6.8 PATENT ANALYSIS
6.8.1 PATENT PUBLICATION TRENDS FOR GASTROINTESTINAL STENTS
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN GASTROINTESTINAL STENT MARKET, 2015-2021
6.8.2 TOP APPLICANTS (COMPANIES) OF GASTROINTESTINAL STENTS PATENTS
FIGURE 29 TOP COMPANIES THAT APPLIED FOR GASTROINTESTINAL STENTS PATENTS, 2018 AND 2021
6.8.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN GASTROINTESTINAL STENT MARKET
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR GASTROINTESTINAL STENT PATENTS, 2015-2021
6.9 YC-YCC TRENDS/DISRUPTION IMPACTING CUSTOMER BUSINESS
FIGURE 31 YC-YCC SHIFT IN GASTROINTESTINAL STENT MARKET
6.10 IMPACT OF COVID-19 ON GASTROINTESTINAL STENT MARKET
TABLE 11 IMPACT OF COVID-19 ON SALES OF KEY MARKET PLAYERS

7 GASTROINTESTINAL STENT MARKET, BY PRODUCT (Page No. - 78)
7.1 INTRODUCTION
FIGURE 32 BILIARY SEGMENT TO DOMINATE GASTROINTESTINAL STENT MARKET BY 2026
TABLE 12 GLOBAL GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 13 GASTROINTESTINAL STENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.2 BILIARY STENTS
7.2.1 INCREASING PREVALENCE OF BILE DUCT CANCER AND CHRONIC LIVER DISEASE TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 14 BILIARY STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS
TABLE 15 BILIARY STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.3 COLONIC STENTS
7.3.1 RISING DEMAND FOR COLONIC STENTS DUE TO HIGH INCIDENCE OF COLORECTAL CANCER TO DRIVE SEGMENT GROWTH
TABLE 16 COLONIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS
TABLE 17 COLONIC STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.4 DUODENAL STENTS
7.4.1 INCREASING PREVALENCE OF INTESTINAL MALIGNANCY TO ADOPT DUODENAL STENTS
TABLE 18 DUODENAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS
TABLE 19 DUODENAL STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.5 PANCREATIC STENTS
7.5.1 RISING NUMBER OF ERCP AND PTC PROCEDURES TO DRIVE SEGMENT GROWTH
TABLE 20 PANCREATIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS
TABLE 21 PANCREATIC STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.6 ESOPHAGEAL STENTS
7.6.1 INCREASING INCIDENCE OF ESOPHAGEAL CANCER TO DRIVE ESOPHAGEAL STENTS MARKET
TABLE 22 ESOPHAGEAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS
TABLE 23 ESOPHAGEAL STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

8 GASTROINTESTINAL STENT MARKET, BY MATERIAL (Page No. - 88)
8.1 INTRODUCTION
FIGURE 33 SELF-EXPANDING METAL STENTS SEGMENT TO DOMINATE GASTROINTESTINAL STENT MARKET BY 2026
TABLE 24 GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
8.2 SELF-EXPANDING METAL STENTS
8.2.1 INCREASING ADOPTION OF SELF-EXPANDING METAL STENTS IN HOSPITAL SETTINGS TO DRIVE THE SEGMENT
TABLE 25 SELF-EXPANDING METAL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS
TABLE 26 SELF-EXPANDING METAL STENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 27 GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8.2.2 NITINOL STENTS
8.2.2.1 Ease of deployment for nitinol stents to drive segment growth
TABLE 28 NITINOL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS
TABLE 29 NITINOL STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8.2.3 STAINLESS STEEL STENTS
8.2.3.1 Excellent mechanical properties and medical efficiency of stainless-steel stents to support segment growth
TABLE 30 STAINLESS STEEL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS
TABLE 31 STAINLESS STEEL STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8.2.4 OTHER METAL STENTS
TABLE 32 OTHER METAL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS
TABLE 33 OTHER METAL STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8.3 PLASTIC STENTS
8.3.1 FAVORABLE REIMBURSEMENT POLICIES FOR PLASTIC STENTS AND INCREASED DEMAND FOR SHORT-TERM USE OF STENTS TO DRIVE SEGMENT GROWTH
TABLE 34 PLASTIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS
TABLE 35 PLASTIC STENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

9 GASTROINTESTINAL STENT MARKET, BY APPLICATION (Page No. - 98)
9.1 INTRODUCTION
FIGURE 34 BILIARY DISEASES TO DOMINATE GASTROINTESTINAL STENT MARKET, BY APPLICATION, IN 2026
TABLE 36 GASTROINTESTINAL STENT MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
9.2 BILIARY DISEASES
9.2.1 INCREASED AGING POPULATION AND PREVALENCE OF GALLSTONES TO DRIVE GROWTH
TABLE 37 BILIARY DISEASES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
9.3 GASTROINTESTINAL CANCER
9.3.1 GASTROINTESTINAL CANCER IS THE LARGEST APPLICATION SEGMENT FOR GASTROINTESTINAL STENT
TABLE 38 GASTROINTESTINAL CANCER STENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 39 GASTROINTESTINAL CANCER STENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
9.3.2 COLORECTAL CANCER
9.3.2.1 Rise of colorectal cancer cases to drive segment growth
TABLE 40 COLORECTAL CANCER STENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
9.3.3 STOMACH CANCER
9.3.3.1 High incidence rate of stomach cancer to drive market share for stomach cancer
TABLE 41 STOMACH CANCER STENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
9.3.4 PANCREATIC CANCER
9.3.4.1 Increased prevalence of pancreatic cancer and adoption of stents in endoscopic procedures to drive segment growth
TABLE 42 PANCREATIC CANCER STENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
9.3.5 ESOPHAGEAL CANCER
9.3.5.1 Increasing number of esophageal cancer to increase adoption of esophageal stents
TABLE 43 ESOPHAGEAL CANCER STENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
9.4 IRRI TABLE BOWEL SYNDROME
9.4.1 INCREASED PREVALENCE OF IRRI TABLE BOWEL SYNDROME TO DRIVE DEMAND FOR GI STENTS
TABLE 44 IRRITABLE BOWEL SYNDROME STENT MARKET, BY COUNTRY/REGION, 2019-2026 (USD MILLION)

10 GASTROINTESTINAL STENT MARKET, BY END USER (Page No. - 108)
10.1 INTRODUCTION
FIGURE 35 HOSPITALS & CLINICS SEGMENT TO DOMINATE GASTROINTESTINAL STENT MARKET BY 2026
TABLE 45 GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
10.2 HOSPITALS & CLINICS
10.2.1 HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL STENTS IN HOSPITALS & CLINICS
TABLE 46 REIMBURSEMENT IN HOSPITAL OUTPATIENTS FOR ERCP STENTING PROCEDURES (USD)
TABLE 47 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
10.3 AMBULATORY SURGICAL CENTERS
10.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE AMBULATORY SURGICAL CENTERS
TABLE 48 US: NUMBER OF ASCS, (2013-2018)
TABLE 49 REIMBURSEMENT IN ASC FOR ERCP STENTING PROCEDURES (USD)
TABLE 50 AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

11 GASTROINTESTINAL STENT MARKET, BY REGION (Page No. - 114)
11.1 INTRODUCTION
FIGURE 36 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL SEGMENT DURING FORECAST PERIOD
TABLE 51 GASTROINTESTINAL STENT MARKET, BY REGION, 2019-2026 (USD MILLION)
11.2 NORTH AMERICA
TABLE 52 NORTH AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND 5 YEAR PREVALENCE ( 2020)
FIGURE 37 NORTH AMERICA: GASTROINTESTINAL STENT MARKET SNAPSHOT
TABLE 53 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 54 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 55 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 56 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 57 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 58 NORTH AMERICA: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCERS, 2019-2026 (USD MILLION)
TABLE 59 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.2.1 US
11.2.1.1 US to dominate North America gastrointestinal stent market during forecast period
TABLE 60 US: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER BY GASTROINTESTINAL CANCER (2020)
TABLE 61 US: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 62 US: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 63 US: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 64 US: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 65 US: GASTROINTESTINAL CANCER STENT MARKET, BY GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 66 US: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Growing geriatric population and increased incidence of gastrointestinal disorders to drive gastrointestinal stents demand
TABLE 67 CANADA: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER, BY GASTROINTESTINAL CANCER (2020)
TABLE 68 CANADA: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 69 CANADA: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 70 CANADA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 71 CANADA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 72 CANADA: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 73 CANADA: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3 EUROPE
TABLE 74 EUROPE: GASTROINTESTINAL CANCER INCIDENCE, BY GASTROINTESTINAL CANCER (2020)
FIGURE 38 EUROPE: GASTROINTESTINAL STENT MARKET SNAPSHOT
TABLE 75 EUROPE: GASTROINTESTINAL STENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 76 EUROPE: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 77 EUROPE: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 78 EUROPE: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 79 EUROPE: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 80 EUROPE: GASTROINTESTINAL CANCER STENT MARKET, BY GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 81 EUROPE: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Germany dominated the European gastrointestinal stent market in 2020
TABLE 82 GERMANY: GI CANCER INCIDENCE, IN 2020
TABLE 83 GERMANY: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 84 GERMANY: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 85 GERMANY: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 86 GERMANY: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 87 GERMANY: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 88 GERMANY: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 Favorable statutory health insurance system to boost gastrointestinal stents adoption
TABLE 89 FRANCE: GI CANCER INCIDENCE, (2020)
TABLE 90 FRANCE: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 91 FRANCE: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 92 FRANCE: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 93 FRANCE: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 94 FRANCE: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 95 FRANCE: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.3 UK
11.3.3.1 Increased incidence of gastrointestinal cancers and minimally invasive surgeries to increase gastrointestinal stents adoption
TABLE 96 UK: GASTROINTESTINAL CANCER INCIDENCE (2020)
TABLE 97 UK: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 98 UK: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 99 UK: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 100 UK: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 101 UK: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 102 UK: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Aging population and initiatives to build awareness about digestive health to increase gastrointestinal stent adoption
TABLE 103 ITALY: GASTROINTESTINAL CANCER INCIDENCE (2020)
TABLE 104 ITALY: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 105 ITALY: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 106 ITALY: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 107 ITALY: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 108 ITALY: GASTROINTESTINAL CANCER STENT MARKET, BT GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 109 ITALY: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Increased prevalence of gastrointestinal diseases to raise demand for gastrointestinal stent
TABLE 110 SPAIN: GASTROINTESTINAL CANCER INCIDENCE (2020)
TABLE 111 SPAIN: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 112 SPAIN: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 113 SPAIN: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 114 SPAIN: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 115 SPAIN: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 116 SPAIN: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 117 ROE: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 118 ROE: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 119 ROE: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 120 ROE: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 121 ROE: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 122 ROE: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4 ASIA PACIFIC
TABLE 123 ASIA PACIFIC: GASTROINTESTINAL CANCER INCIDENCE (2020)
FIGURE 39 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET SNAPSHOT
TABLE 124 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 125 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 126 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 127 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 128 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 129 ASIA PACIFIC: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 130 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.1 CHINA
11.4.1.1 Increasing healthcare expenditure and government initiatives to modernize healthcare system and support market growth
TABLE 131 CHINA: GASTROINTESTINAL CANCER INCIDENCE, (2020)
TABLE 132 CHINA: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 133 CHINA: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 134 CHINA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 135 CHINA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 136 CHINA: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 137 CHINA: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Strong healthcare system and increased geriatric population to drive market growth
TABLE 138 JAPAN: GASTROINTESTINAL CANCER INCIDENCE (2020)
TABLE 139 JAPAN: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 140 JAPAN: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 141 JAPAN: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 142 JAPAN: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 143 JAPAN: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 144 JAPAN: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Increasing prevalence of gastrointestinal disorders and presence of global and local market players to drive market growth
TABLE 145 INDIA: GASTROINTESTINAL CANCER INCIDENCE (2020)
TABLE 146 INDIA: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 147 INDIA: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 148 INDIA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 149 INDIA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 150 INDIA: GASTROINTESTINAL STENT MARKET, BY GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 151 INDIA: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC
TABLE 152 ROAPAC: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 153 ROAPAC: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 154 ROAPAC: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 155 ROAPAC: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 156 ROAPAC: GASTROINTESTINAL STENT MARKET, BY GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 157 ROAPAC: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 INCREASING DISPOSABLE INCOME AND BURDEN OF GASTRIC CANCER TO DRIVE MARKET GROWTH
TABLE 158 LATIN AMERICA: GASTROINTESTINAL CANCER INCIDENCE, 2020
TABLE 159 BRAZIL: GASTROINTESTINAL CANCER INCIDENCE, 2020
TABLE 160 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 161 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 162 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 163 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 164 LATIN AMERICA: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 165 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 MIDDLE EAST & AFRICA IS THE SMALLEST MARKET FOR GASTROINTESTINAL STENT PRODUCTS
TABLE 166 MIDDLE EAST & AFRICA: GASTROINTESTINAL CANCER INCIDENCE (2020)
TABLE 167 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019-2026 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019-2026 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 171 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY GASTROINTESTINAL CANCER, 2019-2026 (USD MILLION)
TABLE 172 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY END USER, 2019-2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 167)
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
12.4 KEY PLAYERS RANKING (2020)
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020
12.5 COMPETITIVE BENCHMARKING
12.5.1 COMPANY FOOTPRINT FOR KEY PLAYERS
12.5.2 PRODUCT AND REGIONAL FOOTPRINT OF COMPANIES IN GASTROINTESTINAL STENT MARKET
TABLE 173 PRODUCT TYPE FOOTPRINT OF COMPANIES (20 MARKET PLAYERS)
TABLE 174 MATERIAL FOOTPRINT OF COMPANIES (20 MARKET PLAYERS)
TABLE 175 REGIONAL FOOTPRINT OF COMPANIES (20 MARKET PLAYERS)
12.6 COMPETITIVE LEADERSHIP MAPPING
12.6.1 STARS
12.6.2 EMERGING LEADERS
12.6.3 PERVASIVE PLAYERS
12.6.4 PARTICIPANTS
FIGURE 42 GASTROINTESTINAL STENT MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
12.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
12.7.1 PROGRESSIVE COMPANIES
12.7.2 DYNAMIC COMPANIES
12.7.3 STARTING BLOCKS
12.7.4 RESPONSIVE COMPANIES
FIGURE 43 GASTROINTESTINAL STENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
12.8 COMPETITIVE SCENARIO
12.8.1 PRODUCT LAUNCHES & APPROVALS
TABLE 176 GASTROINTESTINAL STENT MARKET: KEY PRODUCT LAUNCHES & APPROVALS, 2018-2021
12.8.2 DEALS
TABLE 177 GASTROINTESTINAL STENT MARKET: KEY DEALS, 2018-2021

13 COMPANY PROFILES (Page No. - 180)
13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats)*
13.1.1 BOSTON SCIENTIFIC CORPORATION
TABLE 178 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 44 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
13.1.2 COOK GROUP
TABLE 179 COOK GROUP: BUSINESS OVERVIEW
13.1.3 TAEWOONG MEDICAL
TABLE 180 TAEWOONG MEDICAL: BUSINESS OVERVIEW
13.1.4 MICRO-TECH (NANJING) CO., LTD.
TABLE 181 MICRO-TECH (NANJING) CO., LTD.: BUSINESS OVERVIEW
13.1.5 OLYMPUS CORPORATION
TABLE 182 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 45 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)
13.2 OTHER PLAYERS
13.2.1 MERIT MEDICAL SYSTEMS
TABLE 183 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
FIGURE 46 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
13.2.2 BECTON, DICKINSON AND COMPANY
TABLE 184 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 47 BECTON, DICKINSON AND COMPANY.: COMPANY SNAPSHOT (2020)
13.2.3 MEDTRONIC
TABLE 185 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2020)
13.2.4 CANTEL MEDICAL
TABLE 186 CANTEL MEDICAL: BUSINESS OVERVIEW
FIGURE 49 CANTEL MEDICAL: COMPANY SNAPSHOT (2020)
13.2.5 CONMED CORPORATION
TABLE 187 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 50 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
13.2.6 ELLA-CS, S.R.O.
TABLE 188 ELLA-CS, S.R.O.: BUSINESS OVERVIEW
13.2.7 ENDO-FLEX GMBH
TABLE 189 ENDO-FLEX GMBH: BUSINESS OVERVIEW
13.2.8 MI-TECH
TABLE 190 MI-TECH : BUSINESS OVERVIEW
13.2.9 HOBBS MEDICAL INC.
TABLE 191 HOBBS MEDICAL INC.: BUSINESS OVERVIEW
13.2.10 QUALIMED
TABLE 192 QUALIMED: BUSINESS OVERVIEW
13.2.11 UK MEDICAL
TABLE 193 UK MEDICAL: BUSINESS OVERVIEW
13.2.12 CITEC
TABLE 194 CITEC: BUSINESS OVERVIEW
13.2.13 MEDORAH MEDITEK PVT. LTD.
TABLE 195 MEDORAH MEDITEK PVT. LTD.: BUSINESS OVERVIEW
13.2.14 BCM CORPORATION
TABLE 196 BCM CORPORATION: BUSINESS OVERVIEW
13.2.15 LEUFEN MEDICAL GMBH
TABLE 197 LEUFEN MEDICAL GMBH: BUSINESS OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 216)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS